July 14, 2017 / 8:26 PM / 2 months ago

BRIEF-Peregrine Pharmaceuticals Q4 revenue $17.9 million

July 14 (Reuters) - Peregrine Pharmaceuticals Inc

* Peregrine Pharmaceuticals reports financial results for quarter and fiscal year ended April 30, 2017 and recent developments

* Q4 loss per share $0.16

* Q4 revenue $17.9 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below